Related Experiment Video
Updated: Jul 12, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts
Mari Osawa1, Yasuhiko Yamamoto, Seiichi Munesue
1Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
Abstract:
Interactions between advanced glycation endproducts (AGE) and the receptor for AGE (RAGE) have been implicated in the development of diabetic vascular complications. RAGE has two N-glycosylation sites in and near the AGE-binding domain, and G82S mutation in the second N-glycosylation motif was recently reported in human. In this study, we examined whether de-N-glycosylation or G82S of RAGE affect its ability to bind AGE and cellular response to AGE. Recombinant wild-type, de-N-glycosylation and G82S RAGE proteins were produced in COS-7 cells, purified and assayed for ligand-binding abilities. De-N-glycosylation at N81 and G82S mutation decreased Kd for glycolaldehyde-derived AGE to three orders of magnitude lower levels compared with wild-type. AGE-induced upregulation of VEGF mRNA was significantly augmented in endothelial cell-derived ECV304 cells expressing de-N-glycosylated and G82S RAGE when compared with wild-type expressor. Exposure to low glucose resulted in the appearance of RAGE proteins of deglycosylated size in wild-type RAGE-expressing cells and significantly enhanced glycolaldehyde-derived AGE-induced VEGF mRNA expression. De-N-glycosylation or G82S mutation of RAGE increases affinity for AGE ligands, and may sensitize cells or conditions with it to AGE.
Insights
De-N-glycosylation or G82S mutation of the receptor for advanced glycation endproducts (RAGE) enhances its AGE binding affinity. This modification may sensitize cells to AGE, potentially impacting diabetic vascular complications.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Advanced glycation endproducts (AGE) and their receptor (RAGE) interactions are linked to diabetic vascular complications.
- RAGE possesses N-glycosylation sites near its AGE-binding domain, with a G82S mutation identified in humans.
Purpose of the Study:
- To investigate the impact of RAGE de-N-glycosylation and G82S mutation on AGE binding.
- To assess cellular responses to AGE in cells expressing modified RAGE.
Main Methods:
- Production and purification of recombinant wild-type, de-N-glycosylated, and G82S RAGE proteins in COS-7 cells.
- Ligand-binding assays to determine dissociation constants (Kd).
- Analysis of VEGF mRNA expression in ECV304 cells under varying RAGE expression and glucose conditions.
Main Results:
- De-N-glycosylation and G82S mutation significantly decreased the Kd for glycolaldehyde-derived AGE by three orders of magnitude.
- AGE-induced VEGF mRNA upregulation was augmented in cells expressing de-N-glycosylated or G82S RAGE.
- Low glucose conditions induced RAGE deglycosylation and enhanced AGE-induced VEGF mRNA expression.
Conclusions:
- RAGE de-N-glycosylation or G82S mutation increases affinity for AGE ligands.
- These modifications may sensitize cells to AGE, potentially contributing to diabetic vascular complications.
Related Concept Videos
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Glycosylation
Glycosylation occurs in...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Protein Folding Quality Check in the RER
GPCR Desensitization
